First patients receive experimental sarcoma drug in groundbreaking trial

NCT ID NCT06797999

Recruiting now Disease control Sponsor: Adcendo ApS Source: ClinicalTrials.gov ↗

Summary

This is the first time a new drug called ADCE-D01 is being tested in people. The study aims to find a safe and effective dose for adults with advanced soft tissue sarcoma that has spread or cannot be removed by surgery. Researchers will check how the body handles the drug and see if it helps shrink tumors.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Centre Léon Bérard
RECRUITING

Lyon, 69373, France

Contact
Memorial Sloan Kettering Cancer Center
RECRUITING

New York, New York, 10065, United States

Contact
Royal Marsden
NOT_YET_RECRUITING

London, United Kingdom

Contact
Universitair Ziekenhuis Leuven (UZ Leuven) - Campus Gasthuisberg
RECRUITING

Leuven, 3000, Belgium

Contact
University Of Texas MD Anderson Cancer Center
RECRUITING

Houston, Texas, 77030, United States

Contact
University of Colorado Denver
RECRUITING

Aurora, Colorado, 80208, United States

Contact
University of Miami - Sylvester Comprehensive Cancer Center
RECRUITING

Miami, Florida, 33136, United States

Contact
Universitätsklinikum Essen West German Tumor Center
RECRUITING

Essen, D-45147, Germany

Contact

Conditions

Explore the condition pages connected to this study.

METASTATIC SOFT TISSUE SARCOMA UNRESECTABLE SOFT TISSUE SARCOMA